{"id":"NCT03525444","sponsor":"Vertex Pharmaceuticals Incorporated","briefTitle":"A Phase 3 Study of VX-445 Combination Therapy in Subjects With Cystic Fibrosis Heterozygous for the F508del Mutation and a Minimal Function Mutation (F/MF)","officialTitle":"A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-445 Combination Therapy in Subjects With Cystic Fibrosis Who Are Heterozygous for the F508del Mutation and a Minimal Function Mutation (F/MF)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-06-15","primaryCompletion":"2019-04-24","completion":"2019-04-24","firstPosted":"2018-05-15","resultsPosted":"2020-05-19","lastUpdate":"2020-05-19"},"enrollment":405,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Cystic Fibrosis"],"interventions":[{"type":"DRUG","name":"VX-445/TEZ/IVA","otherNames":["VX-445/VX-661/VX-770","VX-445/tezacaftor/ivacaftor"]},{"type":"DRUG","name":"IVA","otherNames":["VX-770","ivacaftor"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"VX-445/TEZ/IVA TC","type":"EXPERIMENTAL"}],"summary":"This study will evaluate the efficacy of VX-445 in triple combination (TC) with tezacaftor (TEZ) and ivacaftor (IVA) in subjects with cystic fibrosis (CF) who are heterozygous for F508del and a minimal function mutation (F/MF subjects).","primaryOutcome":{"measure":"Absolute Change in Percent Predicted Forced Expiratory Volume in 1 Second (ppFEV1)","timeFrame":"From Baseline at Week 4","effectByArm":[{"arm":"Placebo","deltaMin":-0.2,"sd":0.6},{"arm":"VX-445/TEZ/IVA TC","deltaMin":13.6,"sd":0.6}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":3},"locations":{"siteCount":115,"countries":["United States","Australia","Austria","Belgium","Canada","Czechia","France","Germany","Greece","Italy","Netherlands","Sweden","United Kingdom"]},"refs":{"pmids":["37983082","31697873"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":42,"n":201},"commonTop":["Infective pulmonary exacerbation of cystic fibrosis","Cough","Sputum increased","Headache","Nasopharyngitis"]}}